Analysis of the frequency of COPD exacerbations in the 'real-life' DACCORD study over a 2 year period

被引：1
|
作者：
Worth, Heinrich
Buhl, Roland
Criee, Carl-Peter
Kardos, Peter
Mailander, Claudia
Lossi, Nadine
Vogelmeier, Claus
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
COPD; -; exacerbations; management; Epidemiology;
D O I：
10.1183/13993003.congress-2016.PA1118
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1118
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Disease Progression in COPD Patients Classified as Gold D According to Gold 2011 or Gold 2017 in the Real-Life Daccord Study
    Worth, H.
    Kardos, P.
    Criee, C.
    Berschneider, K.
    Obermoser, V.
    Vogelmeier, C.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [32] Effect of 5 years of treatment with mucoactive drugs on COPD exacerbations in the Czech Republic: a real-life study
    Zatloukal, Jaromir
    Page, Clive
    Brat, Kristian
    Svoboda, Michal
    Volakova, Eva
    Koblizek, Vladimir
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] Low rate of exacerbations following initiation of LABA/LAMA fixed-dose combinations: An analysis of the DACCORD real life study
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Vogelmeier, Claus
    Lossi, Nadine
    Worth, Heinrich
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [34] ICS WITHDRAWAL AND TREATMENT WITH A FIXED-DOSE LABA/LAMA COMBINATION: THE GERMAN REAL-LIFE DACCORD COPD COHORT
    Worth, Heinrich
    Kostikas, Konstantinos
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Lossi, Nadine
    Mailaender, Claudia
    Vogelmeier, Claus
    RESPIROLOGY, 2017, 22 : 179 - 179
  • [35] Ics Withdrawal And Treatment With A Fixed-Dose Laba/lama Combination: The German Real-Life Daccord COPD Cohort
    Worth, H.
    Buhl, R.
    Criee, C. -P.
    Kardos, P.
    Lossi, N. S.
    Mailander, C.
    Vogelmeier, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] Classifying Patients as GOLD A-D According to GOLD 2017 Recommendations: An Analysis of the German Real-Life DACCORD Study
    Worth, H.
    Buhl, R.
    Criee, C. P.
    Kardos, P.
    Lossi, N.
    Vogelmeier, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients
    Laurie Pahus
    Pierre-Régis Burgel
    Nicolas Roche
    Jean-Louis Paillasseur
    Pascal Chanez
    BMC Pulmonary Medicine, 19
  • [38] Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients
    Pahus, Laurie
    Burgel, Pierre-Regis
    Roche, Nicolas
    Paillasseur, Jean-Louis
    Chanez, Pascal
    BMC PULMONARY MEDICINE, 2019, 19 (1)
  • [39] Characterization of COPD Patients Experiencing Clinically Relevant Improvement Vs Worsening in Health Status 2 Years After a Change of Maintenance Treatment in the 'Real-life' Daccord Study
    Kardos, P.
    Criee, C.
    Berschneider, K.
    Obermoser, V.
    Vogelmeier, C.
    Buhl, R.
    Worth, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [40] The Key Role of Inhaler Use in COPD: A Real-Life Study
    Molimard, Mathieu
    Raherison, Chantale
    Lamarque, Stephanie
    Lignot-Maleyran, Severine
    Balestra, Aurelie
    Chartier, Anais
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Girodet, Pierre-Olivier
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 596 - 596
12345